| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.003 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |